Zhejiang, China

Zhengzheng Shi

This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengzheng Shi. Retrieved from https://idiyas.com/inventor/zhengzheng-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhengzheng Shi: Innovator in Pharmaceutical Chemistry

Introduction

Zhengzheng Shi is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Zhengzheng Shi holds a patent for a piperazine amide derivative, which is a novel compound with applications in medicine. The patent describes a preparation method for this derivative and its use as a selective Rearranged During Transfection (RET) kinase inhibitor. This invention is represented by a specific formula and includes pharmaceutically acceptable salts, highlighting its potential as a therapeutic agent.

Career Highlights

Zhengzheng Shi is associated with Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work has contributed to the company's reputation in the pharmaceutical industry, particularly in the area of innovative drug development.

Collaborations

Zhengzheng Shi collaborates with talented colleagues, including Panpan Zhang and Sunli Yan. These partnerships enhance the research environment and foster innovation within their projects.

Conclusion

Zhengzheng Shi is a prominent figure in pharmaceutical innovation, with a focus on developing new therapeutic agents. His contributions, particularly through his patent on piperazine amide derivatives, demonstrate his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…